A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : UPDRS-III / Unified Parkinson's Disease Rating Scale

[Related PubMed/MEDLINE]
Total Number of Papers: 295
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   UPDRS-III  (>> Co-occurring Abbreviation)
Long Form:   Unified Parkinson's Disease Rating Scale
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2022 A meta-analysis evaluating effects of the rotigotine in Parkinson's disease, focusing on sleep disturbances and activities of daily living. ADL, AEs, PD, PDSS, RCTs, TP
2022 A Panel of Plasma Biomarkers for Differential Diagnosis of Parkinsonian Syndromes. Abeta40, Abeta42, APD, HCs, MMSE, MSA, NfL, PD, PDSs
2022 Assessing Mild Cognitive Impairment in Parkinson's Disease by Magnetic Resonance Quantitative Susceptibility Mapping Combined Voxel-Wise and Radiomic Analysis. HCs, MCI, MoCA-B, PD, PD-MCI
2022 Association between sleep disturbances and pain subtypes in Parkinson's disease. ADL, HAM-A, HAMD, KPPS, LEDD, MMSE, PD, PSQI, VAS
2022 Changes in elbow flexion EMG morphology during adjustment of deep brain stimulator in advanced Parkinson's disease. DBS, EMG, PD
2022 Correlation between Electrode Location and Anxiety Depression of Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease. HAM-A, HAM-D, IQR, MNI, PD, STN-DBS, VTA
2022 Effect of Theta Burst Stimulation-Patterned rTMS on Motor and Nonmotor Dysfunction of Parkinson's Disease: A Systematic Review and Metaanalysis. cTBS, DLPFC, iTBS, PD, rTMS, SMA, TBS
2022 Effects of Endurance Training on Motor Signs of Parkinson's Disease: A Systematic Review and Meta-Analysis. CEPTT, ET, MDS-UPDRS-III, PD, RCTs
2022 Effects of melatonin prolonged-release on both sleep and motor symptoms in Parkinson's disease: a preliminary evidence. ESS, PD, PR, PSQI
10  2022 Efficacy of Traditional Chinese Exercise in Improving Gait and Balance in Cases of Parkinson's Disease: A Systematic Review and Meta-analysis. 6MWT, BBS, PD, RCTs, TCE, TUG
11  2022 Gender Differences in Pain Subtypes among Patients with Parkinson's Disease. ADL, HAM-A, HAMD, KPPS, LEDD, MMSE, PD, PSQI
12  2022 Lee Silverman Voice Treatment to Improve Speech in Parkinson's Disease: A Systemic Review and Meta-Analysis. LSVT, LSVT, PD, RCTs, RET, SPL, STSD
13  2022 Living in a rural area: a potential risk factor for falls in people with Parkinson disease. CI, MMSE, OR, PD
14  2022 MRI-guided DBS of STN under general anesthesia for Parkinson's disease: results and microlesion effect analysis. DBS, MLE, STN
15  2022 Pain Assessment in Chinese Parkinson's Disease Patients Using King's Parkinson's Disease Pain Scale. ADL, HAM-A, HAMD, KPPS, LEDD, MMSE, PD, PSQI, VAS
16  2022 Patients with Parkinson's disease and a history of falls have decreased cerebellar grey matter volumes in the cognitive cerebellum. GM, MoCA, PD, TMT-A
17  2022 Predicting UPDRS Motor Symptoms in Individuals With Parkinson's Disease From Force Plates Using Machine Learning. PD
18  2022 Resting-State Functional Network Topology Alterations of the Occipital Lobe Associated With Attention Impairment in Isolated Rapid Eye Movement Behavior Disorder. AVLT, HCs, iRBD, rs-fMRI, SDMT, TMT-A
19  2022 Serum NFL discriminates Parkinson disease from essential tremor and reflect motor and cognition severity. ET, H-Y, MMSE, NfL, PD
20  2022 The Cerebellum is Involved in Motor Improvements After Repetitive Transcranial Magnetic Stimulation in Parkinson's Disease Patients. fALFF, fMRI, PD, rs-fMRI, rTMS, SMA
21  2022 The Effects of Different Anesthesia Methods on the Treatment of Parkinson's Disease by Bilateral Deep Brain Stimulation of the Subthalamic Nucleus. GA, HAMA, iMER, LA, LEDD, PD, STN-DBS
22  2022 The Impact of Triangle Hierarchical Management on Self-Management Behavior and Quality of Survival in Parkinson's Patients. FGA, MoCA, PD
23  2021 A Mobile Phone App-Based Tai Chi Training in Parkinson's Disease: Protocol for a Randomized Controlled Study. 6MWT, BBS, FRT, PD, TUG
24  2021 An equation to calculate UPDRS motor severity for online and rural assessments of Parkinson's. ---
25  2021 An international, randomized, placebo-controlled, phase 2b clinical trial of intepirdine for dementia with Lewy bodies (HEADWAY-DLB). DLB
26  2021 Assessment of Motor Dysfunction with Virtual Reality in Patients Undergoing [123I]FP-CIT SPECT/CT Brain Imaging. AUC, PD, ROC, SVM, VR
27  2021 Boxing vs Sensory Exercise for Parkinson's Disease: A Double-Blinded Randomized Controlled Trial. PD
28  2021 Characteristics and risk factors of lower urinary tract dysfunction in patients with Parkinson's disease: A systematic evaluation and meta-analysis. CI, H-Y, MD, MMSE, OR, PD
29  2021 Clinical features and relative factors of constipation in a cohort of Chinese patients with Parkinson's disease. HAMA, HAMD, MoCA, NMS, NMSS, PD, PDQ-39
30  2021 Closed-loop programming using external responses for deep brain stimulation in Parkinson's disease. CLA, DBS, PD, SOC
31  2021 Cognition, motor symptoms, and glycolipid metabolism in Parkinson's disease with depressive symptoms. Chol, FPG, HAMD-17, MoCA, PD, UA
32  2021 Comparative Analysis of Acute Levodopa Challenge Test and the Outcomes of Deep Brain Stimulation in Parkinson's Disease. DBS, PD
33  2021 Determinants of quality of life in Parkinson's disease: a perspective of novel clinical subtypes. ESS, GDS, NMSQ, PD, QoL
34  2021 Development and Initial Validation of the Chinese Version of the Florida Surgical Questionnaire for Parkinson's Disease. DBS, FLASQ-PD, PD
35  2021 Effects of Levodopa Therapy on Cerebral Arteries and Perfusion in Parkinson's Disease Patients. CBF, pCASL, PD, SNAP
36  2021 Effects of resistance training on postural control in Parkinson's disease: a randomized controlled trial. PD, RT, SP
37  2021 Efficacy of dance for Parkinson's disease: a pooled analysis of 372 patients. BBS, CI, MD, PD, TUG
38  2021 Ensemble deep model for continuous estimation of Unified Parkinson's Disease Rating Scale III. CNN, LSTM, PD, PwP
39  2021 Evaluation of the Direct Effect of Bilateral Deep Brain Stimulation of the Subthalamic Nucleus on Levodopa-Induced On-Dyskinesia in Parkinson's Disease. DBS, LEDD, PD, STN, UDysRS
40  2021 Fields of Forel Brain Stimulation Improves Levodopa-Unresponsive Gait and Balance Disorders in Parkinson's Disease. CI, DBS, FOG, PD
41  2021 Gamma Oscillations and Coherence Are Weaker in the Dorsomedial Subregion of STN in Parkinson's Disease. DBS, LFP, PD, PSD, STN
42  2021 High Prevalence of Early Parkinson's Disease in Patients With Subtle Parkinsonian Signs. AI, PD, SBR
43  2021 Long-Term Efficacy and Safety of Zonisamide for Treatment of Parkinsonism in Patients With Dementia With Lewy Bodies: An Open-Label Extension of a Phase three Randomized Controlled Trial. DLB
44  2021 Low-Dose Niacin Supplementation Improves Motor Function in US Veterans with Parkinson's Disease: A Single-Center, Randomized, Placebo-Controlled Trial. PD
45  2021 Motor Asymmetry and Interocular Retinal Thickness in Parkinson's Disease. AIRT, MRT, OCT, PD, pRNFLT
46  2021 Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson Disease. CSF, NfL, PD
47  2021 Prefrontal Physiomarkers of Anxiety and Depression in Parkinson's Disease. BDI, DBS, PD, PFC
48  2021 Progression in Parkinson's Disease: Variation in Motor and Non-motor Symptoms Severity and Predictors of Decline in Cognition, Motor Function, Disability, and Health-Related Quality of Life as Assessed by Two Different Methods. BSS, EQ, HRQL, HY, MoCA, MS, NMS, NMSS, PD, UPDRS II, VAS
49  2021 Progression of Clinical Features in Lewy Body Dementia Can Be Detected Over 6 Months. DCFS, DLB, MMSE, NPI, PDD
50  2021 Progressive microstructural alterations in subcortical nuclei in Parkinson's disease: A diffusion magnetic resonance imaging study. DKI, EPD, GP, HC, MK, MLPD, PD, RK
51  2021 Rehabilitation of Falls in Parkinson's Disease: Self-Perception vs. Objective Measures of Fall Risk. PD, QoL
52  2021 Relationship between electrode position of deep brain stimulation and motor symptoms of Parkinson's disease. LEDD, MNI, PD, VTA
53  2021 Serum Folate, Vitamin B12 Levels, and Systemic Immune-Inflammation Index Correlate With Motor Performance in Parkinson's Disease: A Cross-Sectional Study. H-Y, PD, PNI, SII, VitB12
54  2021 Serum levels of lipocalin-2 in patients with Parkinson's disease. ELISA, HC, LCN2, MoCA, PD
55  2021 Sign-specific stimulation 'hot' and 'cold' spots in Parkinson's disease validated with machine learning. ---
56  2021 Simple Smartphone-Based Assessment of Gait Characteristics in Parkinson Disease: Validation Study. HAM-A, HAM-D, MoCA, PD
57  2021 Speech Characteristics of Patients with Parkinson's Disease-Does Dopaminergic Medications Have a Role? MDVP, PD, VHI
58  2021 Sphingosine-1-Phosphate, Motor Severity, and Progression in Parkinson's Disease (MARK-PD). MARK-PD, MoCA, PD, S1P
59  2021 The Accuracy of Direct Targeting Using Fusion of MR and CT Imaging for Deep Brain Stimulation of the Subthalamic Nucleus in Patients with Parkinson's Disease. CT, DBS, ED, LEDD, MER, MRI, PD, STN
60  2021 The Application of Zonisamide to Patients Suffering from Dementia with Lewy Bodies: Emerging Clinical Data. DLB, MMSE, NPI-10, PD
61  2021 The effect of levodopa on bilateral coordination and gait asymmetry in Parkinson's disease using inertial sensor. GA, PCI, PD, PIGD
62  2021 The Feasibility and Positive Effects of Wuqinxi Exercise on the Cognitive and Motor Functions of Patients with Parkinson's Disease: A Pilot Study. FAB, PD, TUG
63  2021 The longevity gene Klotho and its cerebrospinal fluid protein profiles as a modifier for Parkinsons disease. CSF, PD, PPMI
64  2021 The Trajectory of Motor Deterioration to Death in Parkinson's Disease. PD
65  2020 A Randomized, Controlled Trial of Exercise for Parkinsonian Individuals With Freezing of Gait. PD
66  2020 A systematic review and meta-analysis of safety and efficacy of safinamide for motor fluctuations in patients with Parkinson's disease. MD, RR
67  2020 A validated measure of rigidity in Parkinson's disease using alternating finger tapping on an engineered keyboard. PD
68  2020 Analyzing the effects of PDSAFEx™ on the motor symptoms of Parkinson's disease: A retrospective study. PD
69  2020 Base-peak assessment of levodopa response and detection of fluctuating patients in Parkinson's disease. MID, PD
70  2020 Brain TRODAT-SPECT Versus MRI Morphometry in Distinguishing Early Mild Parkinson's Disease from Other Extrapyramidal Syndromes. PD, SBR, SPECT
71  2020 Characterizing the heterogeneous metabolic progression in idiopathic REM sleep behavior disorder. HC, PD, PET, REM
72  2020 Clinical Relevance of Standardized Mobile Gait Tests. Reliability Analysis Between Gait Recordings at Hospital and Home in Parkinson's Disease: A Pilot Study. PD, TUG
73  2020 Cognitive and motor correlates of grey and white matter pathology in Parkinson's disease. DRS, PD, WMH
74  2020 Combined Unilateral Subthalamic Nucleus and Contralateral Globus Pallidus Interna Deep Brain Stimulation for Treatment of Parkinson Disease: A Pilot Study of Symptom-Tailored Stimulation. DBS, GPi, PD, STN, TUG
75  2020 Comprehensive assessment of levodopa-carbidopa intestinal gel for Turkish advanced Parkinson’s disease patients AE, CGI, LCIG, PD, PEG-J
76  2020 Cortical thickness in visuo-motor areas is related to motor outcomes after STN DBS for Parkinson's disease. DBS
77  2020 Determinants of Quality of Life According to Cognitive Status in Parkinson's Disease. ESS, GDS, LED, PD-MCI, QoL
78  2020 Differences in performance on English and Hebrew versions of the MoCA in Parkinson's patients. MoCA, PD
79  2020 Disease Progression in Patients with Parkin-Related Parkinson's Disease in a Longitudinal Cohort. GU-EOPD
80  2020 Effect of Directional Deep Brain Stimulation on Sensory Thresholds in Parkinson's Disease. DBS, PD, PW, QST, TEED
81  2020 Effects of anodal transcranial direct current stimulation on cognitive dysfunction in patients with progressive supranuclear palsy. PSP, tDCS
82  2020 Efficacy and safety of atypical antipsychotics for psychosis in Parkinson's disease: A systematic review and Bayesian network meta-analysis. BPRS, CGIS, PD
83  2020 Fixel-based analysis reveals fiber-specific alterations during the progression of Parkinson's disease. ANOVA, CC, CST, FD, HAMA, HAMD-17, HCs, MS, PD, SCP
84  2020 Hypomimia in Parkinson's disease: an axial sign responsive to levodopa. PD
85  2020 Impact of Obstructive Sleep Apnea on Cognitive and Motor Functions in Parkinson's Disease. CI, MD, MMSE, MoCA, OSA, PD
86  2020 Inhaled levodopa in Parkinson's disease patients with OFF periods: A randomized 12-month pulmonary safety study. OC, PGIC
87  2020 Intraoperative Neurophysiologic Assessment in Deep Brain Stimulation Surgery and its Impact on Lead Placement. AE, DBS, DSP, LEDD, MER, MS, PSP
88  2020 Levodopa Changes Functional Connectivity Patterns in Subregions of the Primary Motor Cortex in Patients With Parkinson's Disease. FC, GRF, HCs, mdTHA, PD, ROIs
89  2020 Outcomes of STN-DBS in PD Patients With Different Rates of Disease Progression Over One Year of Follow-Up. PD, STN-DBS
90  2020 Predictors of second-sided deep brain stimulation for Parkinson's disease. DBS, GPi, PD
91  2020 Real-world safety and effectiveness of rotigotine in patients with Parkinson's disease: analysis of a post-marketing surveillance study in Japan. ADR
92  2020 Reduced serum SIRT1 levels in patients with Parkinson's disease: a cross-sectional study in China. ELISA, H-Y stage, MMSE, PD, ROC, SIRT1
93  2020 The pattern of FP-CIT PET in pure white matter hyperintensities-related vascular parkinsonism. 18F-FP-CIT, DAT, PD, ROC, VaP, WMH
94  2020 The safety and feasibility of a Halliwick style of aquatic physiotherapy for falls and balance dysfunction in people with Parkinson's Disease: A single blind pilot trial. BBS, mFES, PD
95  2020 Use of Functional MRI to Assess Effects of Deep Brain Stimulation Frequency Changes on Brain Activation in Parkinson Disease. DBS, fMRI, GPe, PD, STN
96  2019 A metabolic profile of polyamines in parkinson disease: A promising biomarker. DTI, PD
97  2019 Altered Global Synchronizations in Patients With Parkinson's Disease: A Resting-State fMRI Study. AAL, DC, FAB, IPL, MTG, NC, PD, rs-fMRI, STG
98  2019 Assessment of visual misperceptions in patients with Parkinson's disease using single and bistable percepts as testing tools. FAB, MMSE, PD, SD, VMs
99  2019 Association of Subthalamic Deep Brain Stimulation With Motor, Functional, and Pharmacologic Outcomes in Patients With Monogenic Parkinson Disease: A Systematic Review and Meta-analysis. LEDD, STN-DBS
100  2019 Cerebral blood flow and cerebrovascular reactivity correlate with severity of motor symptoms in Parkinson's disease. ASL, CBF, CVR, FDR, HCs, MRI, NVU, PD